Anesth Analg 2000;90:638-641
© 2000 International Anesthesia Research Society
OBSTETRIC ANESTHESIA
The Inhibition of Epidural Morphine-induced Pruritus by Epidural Droperidol
Marcio L. Horta, MD,
Lourenço Ramos, MD, and
Zonia R. Gonçalves, MD
Departments of Anesthesiology, Santa Casa de Misericórdia de Pelotas, and Hospital Universitário São Francisco de Paula da UCPEL, Pelotas, RS, Brazil
Address correspondence and reprint requests to Dr. Marcio Leal Horta, Rua Anchieta, 4043, 96015.420-Pelotas-Rs, Brazil. Address e-mail to marciolhorta{at}uol.com.br
IV droperidol inhibits epidural morphine-induced pruritus, but this effect disappears when the dose is increased from 2.5 to 5.0 mg. This study was performed to determine whether epidural droperidol would have a similar effect. In this double-blinded study, we enrolled 140 patients undergoing Cesarean delivery under epidural anesthesia who were randomly allocated to four groups. Anesthesia consisted of 150 mg of 0.5% bupivacaine with 1:200,000 epinephrine, with 2 mg of morphine and 0.0, 1.25, 2.5, or 5.0 mg of droperidol (Groups 1 to 4). During the postoperative period, patients were assessed for pruritus (absent, mild, moderate, or severe) and other untoward symptoms. The 2 test was used to compare the incidence of the side effects. For the analysis of pruritus, we used the Mantel-Haenszel test for linear association. Droperidol induced a dose-related reduction in the incidence of pruritus (P < 0.001). This reduction was independent of the incidence of somnolence, which increased with droperidol dose (P < 0.05 when the incidence of somnolence in Groups 1 and 4 was compared). We conclude that droperidol, in doses up to 5 mg epidurally, induces a dose-related reduction in the incidence of pruritus without inducing significant side effects.
Implications: Epidural morphine is effective for pain control but yields some side effects, including pruritus, that can be severe. Studying patients undergoing Cesarean delivery, we found a dose-related reduction in the incidence of pruritus using epidural droperidol.
This article has been cited by other articles:

|
 |

|
 |
 
S. L. Shafer
Anesthesia & Analgesia's Policy on Off-Label Drug Administration in Clinical Trials
Anesth. Analg.,
July 1, 2007;
105(1):
13 - 15.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. H. Lee and I. O. Lee
The Antipruritic and Antiemetic Effects of Epidural Droperidol: A Study of Three Methods of Administration
Anesth. Analg.,
July 1, 2007;
105(1):
251 - 255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ben-David, P. J. DeMeo, C. Lucyk, and D. Solosko
Minidose Lidocaine-Fentanyl Spinal Anesthesia in Ambulatory Surgery: Prophylactic Nalbuphine Versus Nalbuphine Plus Droperidol
Anesth. Analg.,
December 1, 2002;
95(6):
1596 - 1600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ekatodramis, B. Hutter, A. Borgeat, M. L. Horta, L. Ramos, and Z. R. Goncalves
Inhibition of Epidural Morphine-Induced Pruritus by Epidural Droperidol Response
Anesth. Analg.,
October 1, 2000;
91(4):
1039 - 1040.
[Full Text]
[PDF]
|
 |
|
|